Paul Wachter, Director at Avalanche Biotechnologies, Inc. ([AAVL]), sold 1,192 shares at $38.30 ($44K) on 2015-05-26, disclosed to the SEC on 2015-05-27.
Scheduled sale ($44k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.52 | 786 | $29K | 65.2% |
| 2 | $37.59 | 304 | $11K | 25.9% |
| 3 | $38.30 | 102 | $4K | 8.9% |
| Total | $36.95 avg | 1,192 | $44K | 100% |
| Filing → |
| [AAVL] | SELL | 2015-06-10 | $46K | — | Filing → |
| [AAVL] | SELL | 2015-06-02 | $43K | — | Filing → |
| [AAVL] | SELL | 2015-05-19 | $42K | — | Filing → |